Visceral Adiposity Index in Breast Cancer Survivors: A Case-Control Study.

Autor: Cardoso-Peña E; Family Medicine Unit No. 220, Mexican Institute of Social Security, Toluca, Mexico.; School of Medicine, Autonomous University of the State of Mexico, Toluca, Mexico., Soto Pina AE; School of Medicine, Autonomous University of the State of Mexico, Toluca, Mexico., Villanueva ÁG; Regional General Hospital No. 251, Mexican Institute of Social Security, Metepec, Mexico., López Chavez GE; Regional General Hospital No. 251, Mexican Institute of Social Security, Metepec, Mexico., Ramírez Martínez P; Regional General Hospital No. 251, Mexican Institute of Social Security, Metepec, Mexico., Ramírez Montoya H; Regional General Hospital No. 251, Mexican Institute of Social Security, Metepec, Mexico., Berumen Lechuga MG; Delegation of the State of Mexico West, Mexican Institute of Social Security, Toluca, Mexico., Benitez Arciniega AD; School of Medicine, Autonomous University of the State of Mexico, Toluca, Mexico., Alarcón Fortepiani ML; Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, TX, USA.; Department of Cellular and Integrative Physiology, UT Health, San Antonio, TX, USA., Valdés Ramos R; School of Medicine, Autonomous University of the State of Mexico, Toluca, Mexico., Garduño García JJ; School of Medicine, Autonomous University of the State of Mexico, Toluca, Mexico.; Regional General Hospital No. 251, Mexican Institute of Social Security, Metepec, Mexico.
Jazyk: angličtina
Zdroj: International journal of endocrinology [Int J Endocrinol] 2020 Dec 09; Vol. 2020, pp. 8874916. Date of Electronic Publication: 2020 Dec 09 (Print Publication: 2020).
DOI: 10.1155/2020/8874916
Abstrakt: Background: Breast cancer (BC) is the first cause of cancer morbidity and mortality in women. This disease has been linked to obesity; however, it is not clear how fat accumulation affects women who survive breast cancer. Although the visceral adiposity index (VAI) is a marker of cardiometabolic risk and adipose tissue dysfunction, it is not clear how it changes in breast cancer survivors. The aim of this investigation was to compare VAI in women with and without breast cancer.
Methods: A case-control cross-sectional study was conducted on women who were BC survivors and women without the history of BC (control group). Body composition was assessed using electrical bioimpedance while VAI by means of waist circumference (WC), body mass index (BMI), triacylglycerols (TG), and high-density lipoprotein cholesterol (HDL-C).
Results: 49 women in the BC survivor group and 50 in the control group. WC was wider in the survivor group as regards control (93.65 ± 10.48 vs. 88.52 ± 9.61 cm) ( p =0.025); at once, TG and VAI were significantly higher for the survivor group (243.55 ± 199.84 vs. 159.84 ± 75.77) ( p =0.007) and (11.03 ± 11.15 vs. 6.41 ± 3.66) ( p < 0.005), respectively. Body composition parameters were similar in both groups.
Conclusions: VAI is higher in women who are BC survivors in comparison with controls matched by age and bodyweight.
Competing Interests: The authors declare that they have no conflicts of interest.
(Copyright © 2020 Elías Cardoso-Peña et al.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje